Target- |
MechanismPlatelet aggregation inhibitors |
|
|
|
|
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.SE |
First Approval Date24 Jun 1997 |
100 Clinical Results associated with Sanofi-Synthelabo UK Ltd.
0 Patents (Medical) associated with Sanofi-Synthelabo UK Ltd.
100 Deals associated with Sanofi-Synthelabo UK Ltd.
100 Translational Medicine associated with Sanofi-Synthelabo UK Ltd.